HOUSE 2934117th CongressReferred to the Subcommittee on Health.
RAISE Act
- Last Action
- 5/3/2021
Actions
- 2021-05-03Referred to the Subcommittee on Health.
- 2021-04-30Referred to the Subcommittee on Health.
- 2021-04-30Referred to the Subcommittee on Social Security.
- 2021-04-30Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-04-30Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-04-30Introduced in House
- 2021-04-30Introduced in House
CRS Summary
As of 2021-04-30 (00)
Renal Anemia Innovation Support and Expansion Act or the RAISE Act
This bill allows coverage of prescription vitamin and mineral products under the Medicare prescription drug benefit if the products are administered orally and are used to treat iron deficiency anemia in individuals who have chronic kidney disease.
Cosponsors (6)
- Larry Bucshon (R-IN)
- G. K. Butterfield (D-NC)
- Markwayne Mullin (R-OK)
- Dan Crenshaw (R-TX)
- Adrian Smith (R-NE)
- Billy Long (R-MO)
Subjects
- Blood and blood diseases
- Digestive and metabolic diseases
- Health care coverage and access
- Medicare
- Prescription drugs
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.